Home › Funds › Deep Track Capital, LP › COAG
Deep Track Capital, LP position in COAG
HEMAB THERAPEUTICS HOLDINGS · Health Care
Deep Track Capital, LP reported holding 3,602,093 shares of COAG (HEMAB THERAPEUTICS HOLDINGS) in its Q2 2026 13F filing — a position valued at US$132.3M, representing 1.97% of its reported portfolio and ranking #20 among its reported holdings. Deep Track Capital, LP first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Deep Track Capital, LP's COAG position evolved
Deep Track Capital, LP first disclosed a stake in COAG in Q2 2026 at 3,602,093 shares (US$132.3M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 3.60M | $132.30M | New |
About COAG and 13F data
COAG (HEMAB THERAPEUTICS HOLDINGS) is a Health Care company. 60 other funds we track also report a position in COAG — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$286.8M), Novo Holdings A/S (US$153.6M), Siren, L.L.C. (US$76.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding COAG
- RA CAPITAL MANAGEMENT, L.P. 7.81M sh · $286.81M · Q2 2026
- Novo Holdings A/S 4.18M sh · $153.55M · Q2 2026
- Siren, L.L.C. 2.09M sh · $76.65M · Q2 2026
- Avoro Capital Advisors LLC 1.93M sh · $70.71M · Q2 2026
- Bain Capital Life Sciences Investors, LLC 1.65M sh · $60.60M · Q2 2026
- Rock Springs Capital Management LP 575.43K sh · $21.14M · Q2 2026
- Opaleye Management Inc. 47.65K sh · $1.75M · Q2 2026
More on Deep Track Capital, LP
FAQ
How long has Deep Track Capital, LP held COAG?
Deep Track Capital, LP has disclosed COAG holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Deep Track Capital, LP's current position in COAG?
As of Q2 2026, Deep Track Capital, LP holds 3.60M shares of COAG (HEMAB THERAPEUTICS HOLDINGS), valued at $132.30M, representing 1.97% of its reported portfolio and ranking #20.
Has Deep Track Capital, LP been buying or selling COAG?
In the latest 13F filing (Q2 2026), Deep Track Capital, LP newly opened its position in COAG.
Which other funds hold COAG?
Other major institutional holders of COAG include RA CAPITAL MANAGEMENT, L.P., Novo Holdings A/S, Siren, L.L.C., among 60 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.